FindTrial
Sign In

A Comparative Study of Chaturbeeja Churna and Dashmoola Taila Matra Basti in management of Pain during menses.

A Comparative Study of Chaturbeeja Churna and Dashmoola Taila Matra Basti in the management of Kashtartava w.s.r. to Primary Dysmenorrhea

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029689
Enrollment
30
Registered
2020-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: DASHMOOLA TAILA MATRA BASTI: 60 ML PER DAY, PER RECTUM (AFTER TAKING FOOD), 14 DAYS PRIOR TO ONSET OF MENSTRUAL CYCLE. DURATION- 7 DAYS Control Intervention1: CHATURBEEJA CHURNA: 3GMS

Sponsors

Dsrrau jodhpur karwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with chief complaint of kashtartava negative HIV, VDRL, HBsAG both married and unmarried patient using any type of analgesic during menses patients suffering with kashtartava for more than 2 consecutive cycles

Exclusion criteria

Exclusion criteria: patients suffering from secondary dysmenorrhea patient having organic pathology of uterus patient suffering from systemic disease patient with abnormal values in LFT, RFT and RBC who need emrgency care patient having dysfunctional uterine bleeding patient using OCP/IUCD patient with history of thyroid dysfunction

Design outcomes

Primary

MeasureTime frame
Painless mensusTimepoint: 8 weeks—

Secondary

MeasureTime frame
PAINLESS MENSTRUAL CYCLESTimepoint: 2 month—

Countries

India

Contacts

Public ContactDr Rashmi Sharma

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur Rajasthan

vd_rashmi11@yahoo.com9782371381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026